Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-21-022312
Filing Date
2021-09-09
Accepted
2021-09-09 16:59:39
Documents
47
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 form10-k.htm 10-K 459659
2 ex21-1.htm EX-21.1 1701
3 ex31-1.htm EX-31.1 17456
4 ex31-2.htm EX-31.2 17398
5 ex32-1.htm EX-32.1 5471
6 ex32-2.htm EX-32.2 5372
  Complete submission text file 0001493152-21-022312.txt   1682680

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE FILE lwel-20210331.xml EX-101.INS 145611
8 XBRL SCHEMA FILE lwel-20210331.xsd EX-101.SCH 18722
9 XBRL CALCULATION FILE lwel-20210331_cal.xml EX-101.CAL 28258
10 XBRL DEFINITION FILE lwel-20210331_def.xml EX-101.DEF 62156
11 XBRL LABEL FILE lwel-20210331_lab.xml EX-101.LAB 130505
12 XBRL PRESENTATION FILE lwel-20210331_pre.xml EX-101.PRE 114864
Mailing Address 125 CAMBRIDGE PARK DRIVE SUITE 301 CAMBRIDGE MA 02140
Business Address 125 CAMBRIDGE PARK DRIVE SUITE 301 CAMBRIDGE MA 02140 1 617 430 5222
Luckwel Pharmaceuticals Inc. (Filer) CIK: 0001567098 (see all company filings)

EIN.: 461660653 | State of Incorp.: NV | Fiscal Year End: 0331
Type: 10-K | Act: 34 | File No.: 333-187874 | Film No.: 211245021
SIC: 2834 Pharmaceutical Preparations